Labcorp EVP, Pres of BLS, CMO & CSO Sold Shares Worth Over $744K
Labcorp Holdings' EVP Brian J. Caveney sold 2,000 shares at $372.04 each, totaling $744,080. He now directly owns 34,562 shares, according to an SEC filing.
How this was made

The 30-second read
Why it matters
The insider sale provides fresh data for investors monitoring insider activity.
Market read
A modest insider sell from a senior executive, offering limited trading impetus.
What to watch
No change in Labcorp's operational outlook; the sale size is small relative to market cap.
Background
Form 4 filing discloses insider transactions required by SEC regulations.
Ticker impact
EVP and CMO of Labcorp sold 2,000 shares for $744,080, reducing his stake to 34,562 shares.
likely slight downward pressure as market prices in the insider sell.
Form 4 filing is a primary source; the sale amount is modest but the insider holds a senior position.
Market effects
Minimal impact on the broader healthcare diagnostics sector.
Limited to U.S. markets where Labcorp trades.
Low global relevance.
Counterpoint
The sale could be routine portfolio rebalancing, not a negative signal.
Key entities
- ExecutiveBrian J. Caveney
EVP, President of BLS, CMO & CSO at Labcorp Holdings.


